Login
Companies $ZURA
$1.05 -$0.03 (2.72%) After hours
Zura Bio Ltd logo

Zura Bio Ltd

zurabio.com

What Do They Do?

Develops antibody drug candidates for patients with autoimmune and inflammatory diseases, including hidradenitis suppurativa and systemic sclerosis.

How Do They Make Money?

No revenue reported yet.

How Are They Changing?

Since the FY2025 annual report
  • Nov 9, 2026 TibuSHIELD missed its key endpoints; Zura stopped HS development Zura will continue the systemic sclerosis study and planned polymyalgia rheumatica study.

From no operations to drug development The older report describes a company with no operations formed to combine with another business; the latest describes a biotechnology company developing medicines for autoimmune and inflammatory diseases.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support